動物用抗生物質および抗菌剤の世界市場レポート2025年

動物用抗生物質および抗菌剤の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.3％で74億8,000万米ドルに成長します。予測期間の成長は、新興疾患、世界の人口増加、規制の変更、公衆衛生上の懸念に起因しています。予測期間の主な動向には、代替ソリューション、共同イニシアチブ、カスタマイズされた治療計画、調査投資の増加、ブロックチェーン技術の統合などが含まれます。

今後5年間の成長率7.3％という予測は、前回予測から0.1％の微減を反映しています。この減少は主に米国と他国との間の関税の影響によるものです。インドや中国からのペニシリンやテトラサイクリングレードの原薬に新たに課された関税は、定期的な医薬品不足を引き起こし、国内の製剤メーカーに代替原薬への割高な支払いを強いる可能性が高いです。また、相互関税や、貿易の緊張と制限の高まりによる世界経済と貿易への悪影響により、その影響はより広範囲に及ぶと思われます。

動物由来の食品に対する需要の高まりが、動物用抗生物質および抗菌剤市場の拡大に拍車をかけています。牛乳、卵、肉などの製品は重要な栄養源であり、人間の食生活において重要な役割を果たしています。これらの動物由来食品の生産に携わる企業や機関は、予防措置として動物用抗生物質および抗菌剤を使用することで、健康な、あるいは病気のない牛群を開発することに注力しています。たとえば、FAO（国連食糧農業機関）が2023年6月に発表した報告書によると、2023年の世界の食肉生産量は2022年比で0.8%微増し、3億6,500万トン（枝肉重量換算）に達する見込みです。その結果、動物由来の食品に対する需要の増加が、予測期間中の動物用抗生物質および抗菌剤の需要を牽引すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の動物用抗生物質および抗菌剤：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の動物用抗生物質および抗菌剤市場：成長率分析
• 世界の動物用抗生物質および抗菌剤市場の実績：規模と成長, 2019-2024
• 世界の動物用抗生物質および抗菌剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界の動物用抗生物質および抗菌剤：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の動物用抗生物質および抗菌剤市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• テトラサイクリン
• ペニシリン
• スルホンアミド
• マクロライド
• アミノグリコシド
• リンコサミド
• フルオロキノロン
• セファロスポリン
• その他の抗菌剤および抗生物質
• 世界の動物用抗生物質および抗菌剤市場：配送方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレミックス
• 経口粉末
• 経口溶液
• 注射
• その他の配送方法
• 世界の動物用抗生物質および抗菌剤市場：動物タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 食料生産動物
• コンパニオンアニマル
• 世界の動物用抗生物質および抗菌剤市場、テトラサイクリン、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• オキシテトラサイクリン
• クロルテトラサイクリン
• ドキシサイクリン
• 世界の動物用抗生物質および抗菌剤市場、ペニシリン、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ペニシリンG
• アンピシリン
• アモキシシリン
• 世界の動物用抗生物質および抗菌剤市場、スルホンアミド、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• スルファジミジン
• スルファジアジン
• スルファメトキサゾール
• 世界の動物用抗生物質および抗菌剤市場、マクロライド、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• エリスロマイシン
• タイロシン
• ツラスロマイシン
• 世界の動物用抗生物質および抗菌剤市場、アミノグリコシド、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ゲンタマイシン
• ネオマイシン
• ストレプトマイシン
• 世界の動物用抗生物質および抗菌剤市場、リンコサミド、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• リンコマイシン
• クリンダマイシン
• 世界の動物用抗生物質および抗菌剤市場、フルオロキノロン、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• エンロフロキサシン
• マルボフロキサシン
• 世界の動物用抗生物質および抗菌剤市場、セファロスポリン、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• セフキノム
• セファレキシン
• セフォペラゾン
• 世界の動物用抗生物質および抗菌剤市場、その他の抗菌剤および抗生物質、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ニトロフラン
• フェニコール
• その他の新規抗生物質

第7章 地域別・国別分析

• 世界の動物用抗生物質および抗菌剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の動物用抗生物質および抗菌剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 動物用抗生物質および抗菌剤市場：競合情勢
• 動物用抗生物質および抗菌剤市場：企業プロファイル
  • C. H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Phibro Animal Health Corp. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ashish Life Science Pvt. Limited
• Ayurvet Limited
• Dechra Pharmaceuticals Plc
• Endovac Animal Health
• HIPRA S. A.
• Huvepharma Inc.
• Inovet（V. M. D. nv/sa）
• Kyoritsu seiyaku Corporation
• Lutim Pharma Private Limited
• Neogen Corporation
• Tianjin Ringpu Bio-Technology Co. Ltd.
• UCBVET Animal Health
• Vetoquinol
• Virbac
• Zydus Animal Health Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 動物用抗生物質および抗菌剤市場2029：新たな機会を提供する国
• 動物用抗生物質および抗菌剤市場2029：新たな機会を提供するセグメント
• 動物用抗生物質および抗菌剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Animal antibiotics and antimicrobials refer to veterinary medications designed to combat bacteria or microorganisms by either killing them or limiting their growth and multiplication. These medications serve various purposes in animals, including the treatment of clinical diseases, prevention or control of common disease events, and the enhancement of animal growth.

The main types of animal antibiotics and antimicrobials encompass tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. Tetracyclines, for example, are bacteriostatic and function by reversibly binding to bacterial 30S ribosomes, thereby altering the bacterial cytoplasmic membrane. Tetracyclines are administered in various forms, including premixes, oral powder, oral solutions, and injections. These medications find use in both companion and food-producing animals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The animal antibiotics and antimicrobials market research report is one of a series of new reports from The Business Research Company that provides animal antibiotics and antimicrobials market statistics, including animal antibiotics and antimicrobials industry global market size, regional shares, competitors with a animal antibiotics and antimicrobials market share, detailed animal antibiotics and antimicrobials market segments, market trends and opportunities, and any further data you may need to thrive in the animal antibiotics and antimicrobials industry. This animal antibiotics and antimicrobials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The animal antibiotics and antimicrobials market size has grown strongly in recent years. It will grow from $5.29 billion in 2024 to $5.64 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to disease outbreaks, livestock production growth, regulatory policies, consumer awareness.

The animal antibiotics and antimicrobials market size is expected to see strong growth in the next few years. It will grow to $7.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to emerging diseases, global population growth, regulatory changes, public health concerns. Major trends in the forecast period include alternative solutions, collaborative initiatives, customized treatment plans, rising investments in research, integration of blockchain technology.

The forecast of 7.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Newly imposed tariffs on bulk penicillin- and tetracycline-grade active ingredients from India and China are likely to create periodic drug shortages and compel domestic formulators to pay a premium for substitute sources. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for animal-derived food products is fueling the expansion of the animal antibiotics and antimicrobials market. Products such as milk, eggs, and meat are significant sources of nutrition and play a vital role in human diets. Companies and institutions involved in producing these animal-derived foods are concentrating on developing healthy or disease-free herds by using animal antibiotics and antimicrobials as a precautionary measure. For example, a report released by the Food and Agriculture Organization (FAO) in June 2023 indicates that global meat production is expected to rise modestly by 0.8 percent in 2023, reaching 365 million tonnes (carcass weight equivalent) compared to 2022. Consequently, the increasing demand for animal-derived food products is anticipated to drive the demand for animal antibiotics and antimicrobials during the forecast period.

The anticipated rise in the number of zoonotic diseases is likely to drive the growth of the animal antibiotics and antimicrobials market in the future. Zoonotic diseases are infectious conditions caused by microscopic organisms, infections, and parasites that can be transmitted between animals and humans. Antibiotics and antimicrobials are utilized to treat these diseases, which can result from various pathogens, including bacteria, viruses, fungi, and parasites. Some well-known zoonotic diseases include anthrax, bovine tuberculosis, brucellosis, and hemorrhagic colitis. For instance, a study conducted by FoodNet (Centers for Disease Control and Prevention, USA) reported in June 2023 that there were 25,479 cases of infection, 5,981 hospitalizations, and 170 deaths due to zoonotic diseases in 2022. Thus, the increasing prevalence of zoonotic diseases is expected to propel the animal antibiotics and antimicrobials market in the coming years.

A prominent trend gaining traction in the animal antibiotics and antimicrobials market is strategic partnerships. Companies operating in this sector are forging strategic alliances with pertinent industry players to facilitate research and development in innovative animal antibiotics and antimicrobials. In May 2022, Gnubiotics Sciences, a biotechnology company based in Switzerland dedicated to addressing microbiome-related health conditions in humans and animals, established a partnership with ADM, a US-based developer of human and health nutrition solutions, aimed at commercializing new microbiome solutions targeting companion animal health and wellbeing.

Major companies in the animal antibiotics and antimicrobials market are increasingly concentrating on developing innovative solutions, such as the Antimicrobial Resistance Platform, to mobilize coordinated global efforts against the growing threat of antimicrobial resistance, which poses serious risks to both human and animal health as well as ecosystems. The Antimicrobial Resistance Platform is a collaborative initiative designed to tackle the global challenge of antimicrobial resistance (AMR) by promoting data sharing, surveillance, and coordinated responses across various sectors to combat the emergence of drug-resistant pathogens. For example, in November 2022, the Food and Agriculture Organization of the United Nations (FAO), a specialized agency based in Italy, alongside the United Nations Environment Programme (UNEP) from Kenya, the World Health Organization (WHO) based in Switzerland, and the World Organisation for Animal Health (WOAH) from France, launched the Antimicrobial Resistance Multi-Stakeholder Partnership Platform. This platform serves as an inclusive forum that unites diverse stakeholders from different sectors to collaboratively address AMR through a One Health approach. Its importance lies in enhancing global coordination and awareness, ultimately aiming to maintain the effectiveness of antimicrobials, protect public health, and preserve ecosystems against the escalating threat of AMR.

In July 2022, Dechra Pharmaceuticals, a UK-based pharmaceutical enterprise specializing in animal medicines, completed the acquisition of Piedmont Animal Health for $210 million in cash. This acquisition aligns with Dechra's strategic vision to enhance its pipeline of companion animal pharmaceutical products and expand its team of specialized experts in pharmaceutical research and development, primarily situated in Greensboro. Piedmont Animal Health, based in the United States, is a company dedicated to veterinary pharmaceuticals for companion animals.

Major companies operating in the animal antibiotics and antimicrobials market include C. H. Boehringer Sohn AG & Co. KG, Zoetis Inc., Elanco Animal Health Inc., Merck & Co. Inc., Phibro Animal Health Corp., Ashish Life Science Pvt. Limited, Ayurvet Limited, Dechra Pharmaceuticals Plc, Endovac Animal Health, HIPRA S. A., Huvepharma Inc., Inovet (V. M. D. nv/sa), Kyoritsu seiyaku Corporation, Lutim Pharma Private Limited, Neogen Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., UCBVET Animal Health, Vetoquinol, Virbac, Zydus Animal Health Limited, China Animal Husbandry Co. Ltd., ECO Animal Health Ltd., Nicosia International, Norbrook Laboratories Limited, Biovet AD - Peshtera, BioChek B. V., Bio Agri Mix LP, Bio-Medical Research Ltd., Bioiberica S. A. U., Ceva Sante Animale

North America was the largest region in the animal antibiotics and antimicrobials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal antibiotics and antimicrobials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the animal antibiotics and antimicrobials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The animal antibiotics and antimicrobials market consists of sales of glycopeptides, B-Lactam antibiotics, and polymixins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Animal Antibiotics and Antimicrobials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on animal antibiotics and antimicrobials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for animal antibiotics and antimicrobials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The animal antibiotics and antimicrobials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type of Product: Tetracyclines; Penicillin; Sulfonamides; Macrolides; Aminoglycosides; Lincosamides; Fluoroquinolones; Cephalosporins; Other Antimicrobials And Antibiotics
• 2) By Mode of Delivery: Premixes; Oral Powder; Oral Solution; Injection; Other Modes Of Delivery
• 3) By Animal Type: Food-Producing Animals; Companion Animals
• Subsegments:
• 1) By Tetracyclines: Oxytetracycline; Chlortetracycline; Doxycycline
• 2) By Penicillin: Penicillin G; Ampicillin; Amoxicillin
• 3) By Sulfonamides: Sulfadimidine; Sulfadiazine; Sulfamethoxazole
• 4) By Macrolides: Erythromycin; Tylosin; Tulathromycin
• 5) By Aminoglycosides: Gentamicin; Neomycin; Streptomycin
• 6) By Lincosamides: Lincomycin; Clindamycin
• 7) By Fluoroquinolones: Enrofloxacin; Marbofloxacin; Ciprofloxacin
• 8) By Cephalosporins: Cefquinome; Cephalexin; Cefoperazone
• 9) By Other Antimicrobials And Antibiotics: Nitrofurans; Phenicols; Other Novel Antibiotics
• Companies Mentioned: C. H. Boehringer Sohn AG & Co. KG; Zoetis Inc.; Elanco Animal Health Inc.; Merck & Co. Inc.; Phibro Animal Health Corp.; Ashish Life Science Pvt. Limited; Ayurvet Limited; Dechra Pharmaceuticals Plc; Endovac Animal Health; HIPRA S. A.; Huvepharma Inc.; Inovet (V. M. D. nv/sa); Kyoritsu seiyaku Corporation; Lutim Pharma Private Limited; Neogen Corporation; Tianjin Ringpu Bio-Technology Co. Ltd.; UCBVET Animal Health; Vetoquinol; Virbac; Zydus Animal Health Limited; China Animal Husbandry Co. Ltd.; ECO Animal Health Ltd.; Nicosia International; Norbrook Laboratories Limited; Biovet AD - Peshtera; BioChek B. V.; Bio Agri Mix LP; Bio-Medical Research Ltd.; Bioiberica S. A. U.; Ceva Sante Animale
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Animal Antibiotics and Antimicrobials Market Characteristics

3. Animal Antibiotics and Antimicrobials Market Trends And Strategies

4. Animal Antibiotics and Antimicrobials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Animal Antibiotics and Antimicrobials Growth Analysis And Strategic Analysis Framework

• 5.1. Global Animal Antibiotics and Antimicrobials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Animal Antibiotics and Antimicrobials Market Growth Rate Analysis
• 5.4. Global Animal Antibiotics and Antimicrobials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Animal Antibiotics and Antimicrobials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Animal Antibiotics and Antimicrobials Total Addressable Market (TAM)

6. Animal Antibiotics and Antimicrobials Market Segmentation

• 6.1. Global Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tetracyclines
• Penicillins
• Sulfonamides
• Macrolides
• Aminoglycosides
• Lincosamides
• Fluoroquinolones
• Cephalosporins
• Other Antimicrobials and Antibiotics
• 6.2. Global Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Premixes
• Oral Powder
• Oral Solution
• Injection
• Other Modes of Delivery
• 6.3. Global Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Food-Producing Animals
• Companion Animals
• 6.4. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Tetracyclines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oxytetracycline
• Chlortetracycline
• Doxycycline
• 6.5. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillin G
• Ampicillin
• Amoxicillin
• 6.6. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfadimidine
• Sulfadiazine
• Sulfamethoxazole
• 6.7. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Erythromycin
• Tylosin
• Tulathromycin
• 6.8. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Aminoglycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gentamicin
• Neomycin
• Streptomycin
• 6.9. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Lincosamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lincomycin
• Clindamycin
• 6.10. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enrofloxacin
• Marbofloxacin
• 6.11. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cefquinome
• Cephalexin
• Cefoperazone
• 6.12. Global Animal Antibiotics and Antimicrobials Market, Sub-Segmentation Of Other Antimicrobials And Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nitrofurans
• Phenicols
• Other Novel Antibiotics

7. Animal Antibiotics and Antimicrobials Market Regional And Country Analysis

• 7.1. Global Animal Antibiotics and Antimicrobials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Animal Antibiotics and Antimicrobials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Animal Antibiotics and Antimicrobials Market

• 8.1. Asia-Pacific Animal Antibiotics and Antimicrobials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Animal Antibiotics and Antimicrobials Market

• 9.1. China Animal Antibiotics and Antimicrobials Market Overview
• 9.2. China Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Animal Antibiotics and Antimicrobials Market

• 10.1. India Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Animal Antibiotics and Antimicrobials Market

• 11.1. Japan Animal Antibiotics and Antimicrobials Market Overview
• 11.2. Japan Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Animal Antibiotics and Antimicrobials Market

• 12.1. Australia Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Animal Antibiotics and Antimicrobials Market

• 13.1. Indonesia Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Animal Antibiotics and Antimicrobials Market

• 14.1. South Korea Animal Antibiotics and Antimicrobials Market Overview
• 14.2. South Korea Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Animal Antibiotics and Antimicrobials Market

• 15.1. Western Europe Animal Antibiotics and Antimicrobials Market Overview
• 15.2. Western Europe Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Animal Antibiotics and Antimicrobials Market

• 16.1. UK Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Animal Antibiotics and Antimicrobials Market

• 17.1. Germany Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Animal Antibiotics and Antimicrobials Market

• 18.1. France Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Animal Antibiotics and Antimicrobials Market

• 19.1. Italy Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Animal Antibiotics and Antimicrobials Market

• 20.1. Spain Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Animal Antibiotics and Antimicrobials Market

• 21.1. Eastern Europe Animal Antibiotics and Antimicrobials Market Overview
• 21.2. Eastern Europe Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Animal Antibiotics and Antimicrobials Market

• 22.1. Russia Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Animal Antibiotics and Antimicrobials Market

• 23.1. North America Animal Antibiotics and Antimicrobials Market Overview
• 23.2. North America Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Animal Antibiotics and Antimicrobials Market

• 24.1. USA Animal Antibiotics and Antimicrobials Market Overview
• 24.2. USA Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Animal Antibiotics and Antimicrobials Market

• 25.1. Canada Animal Antibiotics and Antimicrobials Market Overview
• 25.2. Canada Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Animal Antibiotics and Antimicrobials Market

• 26.1. South America Animal Antibiotics and Antimicrobials Market Overview
• 26.2. South America Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Animal Antibiotics and Antimicrobials Market

• 27.1. Brazil Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Animal Antibiotics and Antimicrobials Market

• 28.1. Middle East Animal Antibiotics and Antimicrobials Market Overview
• 28.2. Middle East Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Animal Antibiotics and Antimicrobials Market

• 29.1. Africa Animal Antibiotics and Antimicrobials Market Overview
• 29.2. Africa Animal Antibiotics and Antimicrobials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Animal Antibiotics and Antimicrobials Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Animal Antibiotics and Antimicrobials Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Animal Antibiotics and Antimicrobials Market Competitive Landscape And Company Profiles

• 30.1. Animal Antibiotics and Antimicrobials Market Competitive Landscape
• 30.2. Animal Antibiotics and Antimicrobials Market Company Profiles
  • 30.2.1. C. H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Phibro Animal Health Corp. Overview, Products and Services, Strategy and Financial Analysis

31. Animal Antibiotics and Antimicrobials Market Other Major And Innovative Companies

• 31.1. Ashish Life Science Pvt. Limited
• 31.2. Ayurvet Limited
• 31.3. Dechra Pharmaceuticals Plc
• 31.4. Endovac Animal Health
• 31.5. HIPRA S. A.
• 31.6. Huvepharma Inc.
• 31.7. Inovet (V. M. D. nv/sa)
• 31.8. Kyoritsu seiyaku Corporation
• 31.9. Lutim Pharma Private Limited
• 31.10. Neogen Corporation
• 31.11. Tianjin Ringpu Bio-Technology Co. Ltd.
• 31.12. UCBVET Animal Health
• 31.13. Vetoquinol
• 31.14. Virbac
• 31.15. Zydus Animal Health Limited

32. Global Animal Antibiotics and Antimicrobials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Animal Antibiotics and Antimicrobials Market

34. Recent Developments In The Animal Antibiotics and Antimicrobials Market

35. Animal Antibiotics and Antimicrobials Market High Potential Countries, Segments and Strategies

• 35.1 Animal Antibiotics and Antimicrobials Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Animal Antibiotics and Antimicrobials Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Animal Antibiotics and Antimicrobials Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer